Press Releases
Mar. 12, 2026
98% of Marketers Say Out of Home Is Foundational to Connected Commerce Strategies
Indeterminate
GlobeNewswire, Inc.
Mar. 13, 2026
Inside the Newsroom: EIN Presswire Launches Series on What Journalists Really Look for in Press Releases
Neutral
EIN Presswire
Feb. 20, 2026
Kane Biotech Announces Publication of revyve® Wound Gel Article in the International Wound Journal
Indeterminate
GlobeNewswire, Inc.
Feb. 20, 2026
CAMP4 Therapeutics Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)
Indeterminate
GlobeNewswire, Inc.
Mar. 11, 2026
WHAT ARE THEY SAYING: A New Era for South Caucasus Commerce Thanks to President Trump’s Leadership
Gov't Institution
International Trade Administration - Washington D.C.
Owner: American Government
Feb. 19, 2026
Richard E. Engler, Ph.D., to Speak on TSCA New Chemicals Challenges and Opportunities at GlobalChem 2026
Neutral
EIN Presswire
Feb. 19, 2026
Kane Biotech Expands Commercial Activities in the United States
Indeterminate
GlobeNewswire, Inc.
Mar. 12, 2026
Filana Therapeutics Reports Fourth Quarter and Full Year 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Mar. 13, 2026
Plug-In Hybrid Electric Vehicle Battery Market 2026 Supporting Hybrid Mobility Expansion
Neutral
EIN Presswire
Mar. 12, 2026
Erasca Reports Fourth Quarter and Full Year 2025 Business Updates and Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 18, 2026
Firan Technology Group Corporation (“FTG”) Announces Full Year and Fourth Quarter 2025 Financial Results
Indeterminate
GlobeNewswire, Inc.
Feb. 18, 2026
Tenvie Therapeutics Appoints Don O’Sullivan, Ph.D., MBA, as Chief Business Officer
Indeterminate
GlobeNewswire, Inc.
Mar. 14, 2026
New Alliance Brings Together 1.2 Million Illinois Rare Disease Patients
Neutral
EIN Presswire
Mar. 10, 2026
NAR Existing-Home Sales Report Shows 1.7% Increase in February
Indeterminate
GlobeNewswire, Inc.
Feb. 17, 2026
STAND UP FOR SCIENCE CONDEMNS U.S.-FUNDED HEPATITIS B STUDY IN GUINEA-BISSAU
Neutral
EIN Presswire
Mar. 12, 2026
Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2025 Financial Results and Operational Highlights
Indeterminate
GlobeNewswire, Inc.